In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
The end of the decade is just weeks away, and mutual fund boards are looking ahead to 2020 and the issues and challenges that may land ...
The Securities and Exchange Commission should issue valuation guidance for investment companies. When I was chief counsel in the SEC's Division of Investment Management from 1997 ...
When a mutual fund board brings on a new independent director, the onboarding process can be all-encompassing (and many would argue it should be). Obviously, there ...
Having been associated with the mutual fund industry for over 40 years, I have had the opportunity to witness its growth and evolution. I recently decided ...